Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine as a potential agent for breast cancer therapy
Xiao-Dan Zhong, Lijuan Chen, Xin-Yang Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Cuproptosis‐Inducible Chemotherapeutic/Cascade Catalytic Reactor System for Combating with Breast Cancer
Song Yi Lee, Ji‐Hye Seo, Sungyun Kim, et al.
Small (2023) Vol. 19, Iss. 35
Closed Access | Times Cited: 33
The State-of-the-Art Antibacterial Activities of Glycyrrhizin: A Comprehensive Review
Ru-Yi Chen, Jinjin Shi, Yanjun Liu, et al.
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1155-1155
Open Access | Times Cited: 9
Natural Compounds for Preventing Age-Related Diseases and Cancers
Mi‐Ran Ki, Sol Youn, Dong Hyun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7530-7530
Open Access | Times Cited: 8
Current understanding and future prospects on Berberine for anticancer therapy
Anjana Goel
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 1, pp. 177-200
Closed Access | Times Cited: 22
Targeting PGAM1 in cancer: An emerging therapeutic opportunity
Guan–Jun Yang, Tao Fan, Hai‐Jing Zhong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114798-114798
Closed Access | Times Cited: 27
Cancer Pathways Targeted by Berberine: Role of microRNAs
Mansoor Ali, Deepali Mishra, Rana P. Singh
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5178-5198
Closed Access | Times Cited: 5
The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities
Guan–Jun Yang, Changyun Li, Tao Fan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 645-663
Open Access | Times Cited: 11
Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review
Wan‐Jia Qin, Jinjin Shi, Ru-Yi Chen, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Berberine: A natural modulator of immune cells in multiple sclerosis
Esmaeil Yazdanpanah, Sepehr Dadfar, Alireza Shadab, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 4
The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer
Zhen-Yuan Shi, Changyun Li, Ru-Yi Chen, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107400-107400
Closed Access | Times Cited: 4
Berberine inhibits the progression of breast cancer by regulating METTL3‐mediated m6A modification of FGF7 mRNA
Wei Fu, Lixin Liu, Suiju Tong
Thoracic Cancer (2024) Vol. 15, Iss. 17, pp. 1357-1368
Open Access | Times Cited: 4
Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance
Hanan Elimam, Mahmoud Gomaa Eldeib, Esma Z Kizilaslan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 4
Comprehensive pharmacokinetic profiling and molecular docking analysis of natural bioactive compounds targeting oncogenic biomarkers in breast cancer
Basim Othman, Saba Beigh, Mohammad Albanghali, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Modulation of Wnt/Beta-Catenin Pathway by Major Dietary Phytochemicals Against Breast Cancer Development
Noah Lieb, Amina Tran, Martha Torres, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 194-194
Open Access
Phytoconstituents as emerging therapeutics for breast cancer: Mechanistic insights and clinical implications
Mahalakshmi Devaraji, Punniyakoti T. Veeraveedu
Cancer Pathogenesis and Therapy (2025)
Open Access
Synergistic anti-Triple Negative Breast Cancer Study with Paclitaxel/Berberine Nanoparticle Co-Delivery System
Meng-Lan Wang, Le‐Wei Li, Lifang Tang, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106835-106835
Closed Access
Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy
Gulshan Sharma, Rohil Panwar, Sangeeta Saini, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Exploring Natural Compound Libraries for Breast Cancer Targets: An <i>In Silico</i> Study
Devakeerthana Mantharachalam, Bharath Kumar Chagaleti, G. V. Anjana, et al.
Journal of Natural Remedies (2025), pp. 639-656
Open Access
Coptidis Rhizoma and Berberine as Anti-cancer Drugs: a 10-year updates and future perspectives
Guoming Chen, Chengyu Zhang, J. H. Zou, et al.
Pharmacological Research (2025), pp. 107742-107742
Open Access
The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and Beyond
Meng-Yao Niu, Y. Liu, Jinjin Shi, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 572-572
Open Access | Times Cited: 3
Biosurfactant-amphiphilized hyaluronic acid: A dual self-assembly anticancer nanoconjugate and drug vector for synergistic chemotherapy
Sara E. Badawey, Lamia Heikal, Mohamed Teleb, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132545-132545
Closed Access | Times Cited: 3
Pharmacological Potential of Three Berberine-Containing Plant Extracts Obtained from Berberis vulgaris L., Mahonia aquifolium (Pursh) Nutt., and Phellodendron amurense Rupr
Alexandra Ciorîță, Sabina-Emanuela Erhan, Maria-Loredana Soran, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1339-1339
Open Access | Times Cited: 3
Natural Alkaloids in Cancer Therapy: Berberine, Sanguinarine and Chelerythrine against Colorectal and Gastric Cancer
Anna Duda-Madej, Szymon Viscardi, W. Szewczyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8375-8375
Open Access | Times Cited: 3
Targeting lncRNAs of colorectal cancers with natural products
Woo Jung Sung, Jaewoo Hong
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 9
The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy
Lijuan Chen, Xin-Yang Xu, Xiao-Dan Zhong, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106409-106409
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top